Mobile Menu
WEBINAR

Advances in Genomic Sequencing ONLINE

When: November 30, 2022 Time: 3:00 pm

The sequencing landscape is changing more rapidly than ever before: The cost of sequencing is decreasing (welcome to the $100 genome) and patents are expiring. Recent assumptions around the choice of sequencing provider and equipment may no longer be accurate. How do you make sense of this new, suddenly dynamic sequencing ecosystem?  

Our Advances in Genomic Sequencing ONLINE webinar series will help you with these questions, and others by:  

  • Sharing case studies on dissecting the most complex diseases, from cancer to neurodegenerative disorders using long and short reads  
  • Uncovering the benefits of using a combination of long and short-read sequencing technologies  
  • Giving you the latest insight into which patents are expiring, and which new players are entering the scene  

** Please note, by registering for one webinar in the series you will automatically receive access to the subsequent webinar. ** 

– – – – –

Webinar 1: Exploring Long- and Short-Read Sequencing

Wednesday 30th November at 3pm GMT/ 4pm CET/ 10am EST  

When is long-read sequencing best, and how long is long enough? How can we leverage both technologies to the best of their abilities to better understand the human genome?  

Presentations: 

  • Population-scale assessment of structural variation in frontotemporal dementia
    • Wouter De Coster, Research Associate, University of Antwerp & VIB
  • The molecular screening and therapeutic study: A national precision oncology program
    • David Thomas, Head of Genomic Cancer Medicine, Garvan Institute of Medical Research, Chief Executive Officer, Omico: Australian Genomic Cancer Medicine Centre, Conjoint Professor, St Vincent’s Clinical School, Faculty of Medicine, UNSW
  • Long-read transcriptome sequencing reveals isoform diversity across human neurodevelopment
    • Rosemary Bamford, Research Fellow, University of Exeter Medical School  

– – – – –

Webinar 2: Panel Discussion: Exploring the changing sequencing landscape in 2022 and beyond  

Wednesday 7th December at 3pm GMT/ 4pm CET/ 10am EST

The panellists will help you understand:   

  • The changing sequencing landscapes    
  • Novel (and exciting) technologies that are hitting the market, and when is best to use them   
  • Lessons learned from having completed the human genome   
  • Ethical and legal issues surrounding sequencing and data ownership   

  Panellists:   

  • David Smith, Emeritus Professor, Mayo Clinic   
  • Shawn Baker, Genomics Start-up Advisor/Investor/Consultant, SanDiegOmics   
  • Deanna Church, Independent Consultant, Dmchurch Bio, llc   
  • Michael Andrew Quail, Principal Scientific Manager, Sequencing R&D, Wellcome Sanger Institute   
  • Catalina Lopez-Correa, Chief Scientific Officer, Genome Canada  

– – – – –

Register for Advances in Genomic Sequencing ONLINE here:

Speakers

Wouter De Coster Wouter De Coster, Research Associate, University of Antwerp & VIB

David Thomas David Thomas, Head of Genomic Cancer Medicine, Chief Executive Officer, Conjoint Professor, Garvan Institute of Medical Research, Omico: Australian Genomic Cancer Medicine Centre, St Vincent's Clinical School, Faculty of Medicine, UNSW 

Rosemary Bamford Rosemary Bamford, Research Fellow, University of Exeter Medical School 

David Smith David Smith, Emeritus Professor, Mayo Clinic 

Shawn Baker Shawn Baker, Genomics Start-up Advisor/Investor/Consultant, SanDiegOmics  

Deanna Church Deanna Church, Independent Consultant, Dmchurch Bio, llc  

Michael Andrew Quail Michael Andrew Quail, Principal Scientific Manager, Sequencing R&D, Wellcome Sanger Institute  

Catalina Lopez-Correa Catalina Lopez-Correa, Chief Scientific Officer, Genome Canada 


More on these topics

Genomics / NGS / Sequencing

Share this webinar

Article Search